General features of patients with Pulmonary Langerhans Cell Histiocytosis followed in our instution

ACAT M. , Tanriverdi E., Ugur Chousein E. G. , Demirkol B., Yildirim B. Z. , Turan D., et al.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.66, ss.205-211, 2018 (ESCI İndekslerine Giren Dergi)

  • Cilt numarası: 66 Konu: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5578/tt.67334
  • Dergi Adı: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Sayfa Sayısı: ss.205-211

Özet

Introduction: Pulmonary Langerhans Cell Histiocytosis (PLCH) is a rare disease affecting young smokers. It is more common between the ages of 20-40 and equals the male/female ratio. Lung biopsy is the most useful methods for diagnosis. The first treatment is to quit smoking. Corticosteroids or chemotherapeutic agents can be used in severe progressive cases despite of quiting smoking. The patients with PLCH followed in our clinic were assessed with general clinical features in the light of the literature.